Micropos Medical AB (publ)

Micropos has a current ratio of 3.26, indicating strong short-term liquidity, with no debt on its balance sheet and total liabilities of SEK 5.25 million against total assets of SEK 18.98 million. However, the company reported negative operating cash flow of SEK -21.68 million and free cash flow of SEK -22.47 million, reflecting ongoing operational cash burn. Profitability metrics show significant underperformance relative to industry norms. The company reported a return on equity (ROE) of -158.09% and a return on assets (ROA) of -114.37%, far below the typical positive returns expected in the Advanced Medical Equipment & Technology industry. Gross profit of SEK 9.74 million was insufficient to offset operating expenses, resulting in a net loss of SEK -21.70 million. Revenue is concentrated in the RayPilot product line, with no disclosed segment breakdown. The company's geographic exposure is primarily in the Nordic region, with additional sales through European, U.S., and Asian distributors. No material revenue concentration by geography is reported, but the lack of segment data limits visibility into growth drivers. Outlook for the current fiscal year shows continued operational losses, with no revenue growth or margin improvement indicated in the financial snapshot. The company has not disclosed forward-looking guidance, and historical data suggests a trajectory of declining profitability. No capital expenditure growth is expected, with CAPEX at SEK -1.53 million in the latest period. Risk factors include high liquidity risk due to negative operating and free cash flows, with no debt but no clear path to positive cash flow generation. Dilution risk is currently low, with no difference between basic and diluted shares outstanding, but the absence of a going-concern statement in source documents raises uncertainty about long-term viability. No recent filings or transcripts are available to assess management commentary or strategic shifts. No recent events, such as earnings calls, regulatory updates, or partnership announcements, are disclosed in the source data to inform near-term operational or strategic developments.